Gilead Sciences (GILD)
Latest
-
Gilead Sciences' (GILD) Remdesivir Sparks Market Hope With Trial Success
investing Gilead's COVID-19 treatment shows efficacy in Phase 3 trial, NIAID study
investing -
How to Survive the Economic Fallout from COVID-19
investing The bull market and economic expansion are over. Here's what to do now.
investing -
5 Undervalued Stocks With Free Cash Flow to Burn
stocks Look beyond the P/E. These five firms are inexpensive based on free cash flow.
stocks -
Why I'm Hanging On to a Loser
investing Gilead is way down from when I bought it, but it is flush with cash and has dozens of promising medications in its pipeline.
investing -
Can This Fallen Biotech Be Revived?
investing I've been sorely tempted to sell my Gilead shares. But now that they're cheaper, maybe I should buy more.
investing -
This Stumbling Biotech Stock Still Has a Lot of Promise
investing Gilead Sciences' robust product pipeline should turn things around.
investing -
3 Bargain Stocks to Beat the Market
stocks The Value Line Investment Survey sees a strong year ahead for these picks.
stocks -
Promising Bargains in Biotech Stocks
investing What I like about BioDelivery Sciences is not so much that there are many ways to win as that there are almost no ways to lose.
investing
